Vermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call

AUSTIN, Texas, Aug. 4, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will now report its second quarter 2017 financial results on Wednesday, August 9, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

    Wednesday, August 9th @ 4:30pm Eastern Time
    -------------------------------------------

    Domestic:                           888-437-9274

    International:                      719-325-2437

    Conference
     ID:                                                                             8515049

    Webcast:                            http://public.viavid.com/index.php?id=125153


    Replays, Available through August 23nd

    Domestic:                           844-512-2921

    International:                      412-317-6671

    Replay PIN:                                                                      8515049

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com

View original content:http://www.prnewswire.com/news-releases/vermillion-announces-date-change-of-second-quarter-2017-financial-results-and-investor-conference-call-300499863.html

SOURCE Vermillion, Inc.